Breaking Finance News

Horizon Discovery Group Plc (LON:HZD) target price lowered to 205.00GBX, reported today by Panmure Gordon

Yesterday Horizon Discovery Group Plc (LON:HZD) traded 7.03% lower at 152.50GBX. Horizon Discovery Group Plc’s 50-day moving average is 160.39GBX and its two hundred day average is 160.58GBX. The last stock close is down 4.47% from the 200-day moving average, compared to the S&P 500 Index which has fallen -0.01% over the same period. 967,951 shares of the stock exchanged hands, up from ann average volume of 160,373.

Panmure Gordon dropped the price target of Horizon Discovery Group Plc (LON:HZD) to 205GBX, stating a possible upside of 0.34%,

See Graph Below:

Horizon Discovery Group Plc (LON:HZD)

In addition to Panmure Gordon reporting it’s stock price target, a total of 3 firms have issued a research note on HZD. The average target is 218.67GBX with one analyst rating the company a strong buy, two analysts rating the company a buy, one firm rating the stock a hold, 0 rating the company to underperform, and lastly 0 brokerages rating the stock as sell.

Horizon Discovery Group Plc has a 52 week low of 125.00GBX and a 52 week high of 188.06GBX and has a total market value of 0.0 GBX.

About Horizon Discovery Group Plc (LON:HZD)

Horizon Discovery Group PLC is a gene editing company that designs and engineers genetically-modified cells, applying them in research and clinical applications to advance human health. The Company’s gene editing platform, able to alter almost any gene sequence, has generated a catalogue of over 23, 000 cell and in vivo models that recapitulate the genetic anomalies found in diseases like cancer. These models have been adopted by c1, 400 organizations to better understand of the genetic drivers of disease, and by Horizon in a range of services offered to customers, and as well as in the Company’s own research R&D pipeline.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *